Skip to content
StockMarketAgent
Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/MSK stock hub

FRA/MSK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/MSKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.8B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/MSKFRA/MSK
Loading chart…
In the news

Latest news · FRA/MSK

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.3
P25 n/aP50 n/aP75 n/a
Trailing P/E43.6
P25 n/aP50 n/aP75 n/a
ROE-19.3
P25 n/aP50 n/aP75 n/a
ROIC-3.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/MSK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
171
Groups with data
11
Currency
USD
Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Cayman Islands
Country code
DE
Employees
6,547
Employees Change
200%
Employees Change Percent
3.15
Enterprise value
EUR 2.9B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Surgical and Medical Instruments and Apparatus
Last refreshed
2026-05-10
Market cap
EUR 1.8B
Price
EUR 0.93
Price currency
EUR
Rev Per Employee
129,427.83x
Sic
3841
Symbol
fra/MSK
Website
https://www.microport.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
2.29%
EV Earnings
70.76x
EV/EBITDA
81.75x
EV/Sales
3.48x
Forward P/E
25.25x
P/B ratio
1.41x
P/E ratio
43.61x
P/S ratio
2.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-7.45%
EBITDA Margin
2.77%
Gross margin
55.63%
Gross Profit
EUR 471.4M
Gross Profit Growth
0.26%
Gross Profit Growth3 Y
-1.22%
Gross Profit Growth5 Y
0.4%
Net Income
EUR 41.3M
Pretax Margin
-23.37%
Profit Margin
4.88%
Profit Per Employee
EUR 6,312
ROA
-1.26
Roa5y
-4.18
ROCE
-2.89
ROE
-19.34
Roe5y
-25.97
ROIC
-3.15
Roic5y
-15.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr10y
7.96%
Cagr15y
5.05%
Cagr1y
12.13%
Cagr3y
-21.33%
Cagr5y
-31.35%
Div CAGR3
-1.6%
Div CAGR5
16.2%
Revenue Growth
-3.51x
Revenue Growth3 Y
-1.05x
Revenue Growth5 Y
1.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
EUR 0.27
Assets
EUR 3.1B
Cash
EUR 674.4M
Current Assets
EUR 1.4B
Current Liabilities
EUR 957.4M
Debt
EUR 1.4B
Debt EBITDA
EUR 23.74
Debt Equity
EUR 1.07
Equity
EUR 1.3B
Interest Coverage
-0.7
Liabilities
EUR 1.9B
Long Term Assets
EUR 1.8B
Long Term Liabilities
EUR 913.4M
Net Cash
EUR -688.9M
Net Cash By Market Cap
EUR -38.23
Net Debt EBITDA
EUR 29.4
Net Debt Equity
EUR 0.54
Tangible Book Value
EUR 508M
Tangible Book Value Per Share
EUR 0.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.45
Inventory Turnover
1.21
Net Working Capital
EUR 309.9M
Quick ratio
1.04
Working Capital
EUR 429.7M
Working Capital Turnover
EUR 1.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-7.36%
Dividend per share
EUR 0
Last Dividend
EUR 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
115.08%
1Y total return
12.12%
200-day SMA
1.25
3Y total return
-51.32%
50-day SMA
1.03
50-day SMA vs 200-day SMA
50under200
5Y total return
-84.75%
All Time High
7.77
All Time High Change
-88.1%
All Time High Date
2021-06-22
All Time Low
0.29
All Time Low Change
224.56%
All Time Low Date
2011-08-22
ATR
0.02
Ch YTD
-22.27
High
0.93
High52
1.75
High52 Date
2025-10-08
High52ch
-47.14%
Low
0.93
Low52
0.74
Low52 Date
2025-05-26
Low52ch
25.85%
Ma50ch
-10.02%
Price vs 200-day SMA
-26.06%
RSI
39.81
RSI Monthly
43.5
RSI Weekly
36.21
Sharpe ratio
0.47x
Sortino ratio
0.94
Total Return
-7.36%
Tr YTD
-22.27
Tr15y
109.47%
Tr1m
-7.5%
Tr1w
-0.54%
Tr3m
-20.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -63.1M
Operating margin
-7.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
998,906,861%
Shares Insiders
0.67%
Shares Institutions
17.74%
Shares Yo Y
7.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

47
MetricValue
Average Volume
25x
Bv Per Share
0.44
Ch10y
112.2
Ch15y
97.65
Ch1m
-7.5
Ch1w
-0.54
Ch1y
12.12
Ch3m
-20.26
Ch3y
-51.32
Ch5y
-84.76
Ch6m
-22.92
Change
0.54%
Change From Open
0
Close
0.92
Days Gap
0.54
Depreciation Amortization
86,197,881.2
Earnings Date
2026-03-31
EBIT
EUR -63.1M
EBITDA
EUR 23.4M
EPS
EUR 0.01
F Score
7
Financing CF
-109,962,987
Fiscal Year End
December
Founded
1,998
Goodwill
170,534,485.8
Graham Number
0.55949
Graham Upside
-39.51
Income Tax
EUR 19.8M
Investing CF
13,759,214
Is Primary Listing
0
Last Earnings Date
2026-03-31
Last Report Date
2025-12-31
Ma150
1.19
Ma150ch
-22.14%
Ma20
0.95
Ma20ch
-2.92%
Net CF
-25,965,778
Open
0.93
P OCF Ratio
30.6
Ppne
742,702,781
Price Date
2026-05-08
Price EBITDA
EUR 76.89
Ptbv Ratio
3.55
Relative Volume
6.67x
Revenue
847,363,995x
Tax By Revenue
2.33x
Tr6m
-22.92%
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/MSK pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/MSK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+12.1%
S&P 500 1Y: n/a
3Y total return
-51.3%
S&P 500 3Y: n/a
5Y total return
-84.7%
S&P 500 5Y: n/a
10Y total return
+115.1%
S&P 500 10Y: n/a
Ownership

Who owns FRA/MSK?

Insider, institutional, and short-interest positioning.

Institutional ownership
+17.7%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+7.4%
Negative means the company is buying back shares.
Technical

FRA/MSK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
39.8
Neutral momentum band
Price vs 200-day MA
-26.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.47
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/MSK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/MSK stock rating?

fra/MSK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/MSK analysis?

The full report lives at /stocks/fra/MSK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/MSK?

The latest report frames fra/MSK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/MSK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.